ADBRY vs DUPIXENT

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 9, 2026·How we rate

Possible drug interaction. ADBRY and DUPIXENT are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	ADBRY	DUPIXENT
Rating	New	72/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	TRALOKINUMAB	DUPILUMAB
Manufacturer	Leo Pharma As	Regeneron Pharmaceuticals
Dosage forms	Injectable	Injectable
Drug class	Interleukin-13 Antagonist	Interleukin-4 Receptor Alpha Antagonist
Boxed warning	None	None
Treats	Atopic Dermatitis	Atopic Dermatitis

adbry dupixent

Rating

New

72/100

Pharmacy pays

—

Type

Active ingredient

TRALOKINUMAB

DUPILUMAB

Manufacturer

Leo Pharma As

Regeneron Pharmaceuticals

Dosage forms

Injectable

Drug class

Interleukin-13 Antagonist

Interleukin-4 Receptor Alpha Antagonist

Boxed warning

None

Treats

Atopic Dermatitis

Frequently asked questions

What is the difference between Adbry and Dupixent?

Adbry contains Tralokinumab, while Dupixent contains Dupilumab — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.